Frank Chinegwundoh, of Nigerian descent, qualified in medicine from St George's Hospital Medical School, University of London, in 1984, going on to become the first Black British urological surgeon. His specialist training took him through the West Midlands and Cleveland, Ohio, before his appointment as a Consultant Urological Surgeon to Barts Health NHS Trust and Newham University Hospital in 1996.
In 2006, Chinegwundoh published the first UK research demonstrating that Black men face a three-fold increased risk of developing prostate cancer compared to white men — a landmark finding that reshaped clinical awareness of racial disparities in the disease and has driven two decades of subsequent research and public health campaigning.
Since 1998 he has chaired Cancer Black Care, a charity dedicated to supporting Black and minority ethnic communities affected by cancer, and has co-chaired the Department of Health's Prostate Cancer Advisory Group. He established and leads the regional prostate low-dose brachytherapy service at Barts Health NHS Trust, one of very few urologists in the country able to deliver it.
Chinegwundoh was awarded an MBE for services to the NHS in 2013, having received a National Clinical Excellence Award in 2008 and again in 2013. He continues to combine frontline surgical practice with research into prostate cancer and ethnicity, medical education, and sustained advocacy for better outcomes for Black men within the NHS.
- Recognised as the first Black British urological surgeon
- Published the first UK research (2006) establishing that Black men face a three-fold increased risk of prostate cancer
- Chairman of Cancer Black Care since 1998, supporting Black and minority ethnic communities affected by cancer
- Established and leads the regional prostate low-dose brachytherapy service at Barts Health NHS Trust
- Awarded an MBE for services to the NHS in 2013, alongside two National Clinical Excellence Awards
- Question why the data doesn't exist yet. Chinegwundoh's landmark research began with the recognition that no one had yet formally documented racial disparities in UK prostate cancer risk.
- Combine clinical excellence with community accountability. He has maintained frontline surgical practice throughout decades of charity leadership and public health campaigning.
- Sustain advocacy over decades, not moments. His chairmanship of Cancer Black Care since 1998 reflects long-term institutional commitment rather than a single campaign.
- Bring specialist expertise back to where it's needed. His appointment as Visiting Professor in Nigeria reflects a deliberate effort to share expertise internationally, not just domestically.